Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2026-03-01 @ 4:13 PM
Study NCT ID:
NCT04168203
Status:
COMPLETED
Last Update Posted:
2025-11-14
First Post:
2019-11-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism
Sponsor:
Brigham and Women's Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CV185-745
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None